Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: A single institution experience with 17 cases

European Journal of Surgical Oncology

Volumn 34, Issue 2, 2008, Pages 191-195

  Sellner, F ^a   Sobhian, B ^a   De Santis, M ^a   Pont, J ^a   Staettner, St ^a   Sellner, St ^a   Karner, J ^a   Klimpfinger, M ^a  

^a KAISER FRANZ JOSEF HOSPITAL   (Austria)

Author keywords

Neuroendocrine pancreatic carcinomas; Nonfunctioning; Outcome; Well and poorly differentiated

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NEUROENDOCRINE TUMOR; PANCREAS CARCINOMA; PANCREAS RESECTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, NEUROENDOCRINE; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 38149078871     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.03.008     Document Type: Article

References (24)

1. De Lellis R., Lloyd R., Heitz Ph., and Eng C. WHO classification of tumours. Pathology and genetics of tumours of endocrine organs (2004), IARC Press, Lyon
2. Solcia E., Kloppel G., and Sobin L. WHO histological classification of tumours. Histological typing of endocrine tumours. 2nd ed. (2000), Springer Verlag, Berlin, Heidelberg, New York, Geneva
3. Capella C., Heitz P., Hofler H., Solcia E., and Klöppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and lung. Virchows Arch 425 (1995) 547-560
4. Sobin L.H., and Wittekind Ch. TNM classification of malignant tumours. 6th ed. (2002), John Wiley & Sons, New York
5. Heitz Ph., Komminoth P., Perren A., et al. Pancreatic endocrine tumours: introduction. In: De Lellis R., Lloyd R., Heitz Ph., and Eng C. (Eds). WHO classification of tumours. Pathology and genetics of tumours of endocrine organs (2004), IARC Press, Lyon
6. Dralle H., Krohn S., Karges W., Boehm B., Braukhoff M., and Grimm O. Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors. World J Surg 28 (2004) 1248-1260
7. Matthews B., Heniford B., Reardon P., Brunicardi F., and Greene F. Surgical experience with non-functioning neuroendocrine tumors of the pancreas. Am Surg 66 (2000) 1116-1122
8. Gullo L., Migliori M., Falconi M., et al. Nonfunctioning endocrine tumors: a multicenter clinical study. Am J Gastroenterol 98 (2003) 2435-2439
9. Schindl M., Kaczirek K., Kaserer K., and Niederle B. Is the new classification of neuroendocrine pancreatic tumors of clinical help?. World J Surg 24 (2000) 1312-1318
10. Madura J., Cummings O., Wiebke E., Broadie T., Goulet R., and Howard T. Nonfunctioning islet cell tumors of the pancreas: a difficult diagnosis but one worth the effort. Am Surg 63 (1997) 573-577
11. Kouvaraki M., Solorzano C., Shapiro S., et al. Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol 89 (2005) 170-185
12. Hellmann P., Anderson M., Rastad J., et al. Surgical strategy for large or malignant endocrine pancreatic tumors. World J Surg 24 (2000) 1353-1360
13. Liang H., Wang P., Wang X., Wang J., and Hao X. Management of nonfunctioning islet cell tumors. World J Gastroenterol 10 (2004) 1806-1809
14. Solorzano C., Lee J., Pisters P., et al. Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery 130 (2001) 1078-1085
15. Schwab M., Knoll M., Jentschura D., and Hagmüller E. Hormone-inactive neuroendocrine tumors of the pancreas. Chirurg 68 (1997) 705-709
16. La Rosa S., Sessa F., Capella C., et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch 429 (1996) 323-333
17. Bartsch D., Schilling Th., Ramaswamy A., et al. Management of nonfunctioning islet cell carcinomas. World J Surg 24 (2000) 1418-1424
18. Bordi C., Öberg K., Papotti M., Volante M., and Capella C. Poorly differentiated endocrine carcinoma. In: De Lellis R., Lloyd R., Heitz Ph., and Eng C. (Eds). WHO Classification of tumours. Pathology and genetics of tumours of endocrine organs (2004), IARC Press, Lyon
19. Skogseid B. Nonsurgical treatment of advanced malignant neuroendocrine pancreatic tumors and midgut carcinoids. World J Surg 25 (2001) 700-703
20. Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 12 Suppl. 2 (2001) 111-114
21. Madeira I., Terris B., Voss M., et al. Prognostic factors in patients with endocrine tumors of the duodenopancreatic area. Gut 43 (1998) 422-427
22. Eriguchi N., Aoyagi S., Hara M., Fukuda S., Tanaka F., and Hashimoto M. Nonfunctioning islet cell carcinoma of the pancreas: an evaluation of seven patients who underwent resection followed by long-term survival. Surg Today 29 (1999) 233-237
23. Pivonello R., Ferone D., Filipella M., et al. Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors. J Endocrinol Invest 26 (2003) 82-88
24. Ansell S., Pitot H., Burch P., Kvols L., Mahoney M., and Rubin J. A phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors. Cancer 91 (2001) 1543-1548